I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures
NCT ID: NCT02938039
Last Updated: 2016-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2015-05-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will add up to existing literature about the safety of LMA usage in neonates and infants. Furthermore it may shed some light on which LMA type will be more feasible and effective for neonatal/ infants usage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of I-gel Laryngeal Mask Airway in Pediatric Patients
NCT03748589
Clinical Acceptability of I-GEL® in Pediatric Patients: Comparison of Clinical Performance With Classic-LMA™
NCT01320163
The Comparison of the Clinical Efficacy Between I-gel and LMA-Supreme, the Two Most Recently Developed Supraglottic Airway Devices, in Infants
NCT01863316
Assessment of the I-gel and Air-Q Supraglottic Airways as Conduits for Tracheal Intubation in Children
NCT02189590
A Randomized Comparison of Pediatric I-gel, Air-Q With Classic Laryngeal Mask Airway
NCT02757820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are different types of pediatric LMAs available e.g. I-gel, ProSeal, LMA supreme, LMA classic, LMA unique, LarySeal and Ambu. These devices differ morphologically from each other (silicone, polyvinyl chloride or soft gel). There have been several randomized controlled studies comparing different LMAs in adults, however, the literature is sparse in which such comparison has been made in patients with weight 10 kg or below.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ambu LMA
Ambu Laryngeal Mask Airway device of different sizes for age
Ambu LMA
Ambu Laryngeal Mask Airways
I-Gel LMA
I-Gel Laryngeal Mask Airway device of different sizes for age
I-Gel LMA
I-Gel Laryngeal Mask Airways
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ambu LMA
Ambu Laryngeal Mask Airways
I-Gel LMA
I-Gel Laryngeal Mask Airways
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No muscle relaxant agents
* No other comorbidities
Exclusion Criteria
* Full stomach
* Subjects with upper respiratory tract infection
* Failed caudal block
1 Day
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Saud University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Abdulrahman Alzahem
Associate Professor and Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdulrahman M Alzahem, MD
Role: PRINCIPAL_INVESTIGATOR
King Saud University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E14-1153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.